GGrantIndex
Sort

39,280 grants matching leukemia

Down syndrome: Bridging Genes, Brain and Cognition

$564,782
Julie R Korenberg · University Of Utah · R01 · FY2014 · HD

Transposon-Mediated Gene Therapy for Fanconi Anemia

$564,735
R Scott McIvor · Discovery Genomics, Inc. · R44 · FY2007 · HL

Development Of P2Y Receptor Ligands

$564,699
Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2017 · DK

Studies in the Pathogenesis of Systemic Capillary Leak Syndrome

$564,501
Kirk Druey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI

Development of Novel AIDS Gene Therapy Strategies in the Macaque SHIV Model

$564,464
Hans-Peter Kiem · Fred Hutchinson Cancer Research Center · R01 · FY2012 · AI

Constrained Fetal Hematopoiesis and Clonal Restriction in Fanconi Anemia

$564,423
Peter Kurre · Children'S Hosp Of Philadelphia · R01 · FY2022 · HL

Cytokine-induced epigenetic changes during chronic lung disease

$564,411
Steven Lynn Kunkel · University Of Michigan At Ann Arbor · R01 · FY2016 · HL

Lifecourse determinants and outcomes of epigenetic age acceleration across two generations

$564,305
Christopher Kuzawa · Northwestern University · R01 · FY2019 · AG

EASTERN COOPERATIVE ONCOLOGY GROUP--WISCONSIN STUDIES

$564,243
University Of Wisconsin Madison · U10 · FY2000 · CA

Discovery of Somatic Noncoding Variants that Serve as Drivers in Pediatric Cancers

$564,115
Jinghui Zhang · St. Jude Children'S Research Hospital · R01 · FY2020 · CA

Discovery of Somatic Noncoding Variants that Serve as Drivers in Pediatric Cancers

$564,115
Jinghui Zhang · St. Jude Children'S Research Hospital · R01 · FY2021 · CA

Glia maturation factor-gamma modulation of signaling pathways in macrophages

$564,084
Griffin Rodgers · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL

Transcriptional Repression and Activation by YY1

$564,063
Yang Shi · Boston Children'S Hospital · R01 · FY2010 · GM

Development of ASH1L inhibitors for acute leukemia

$563,962
Jolanta Grembecka · University Of Michigan At Ann Arbor · R01 · FY2022 · CA

Development of ASH1L inhibitors for acute leukemia

$563,962
Jolanta Grembecka · University Of Michigan At Ann Arbor · R01 · FY2023 · CA

Immunology and Pathology of Chronic Murine Leukemia Virus Infections

$563,953
Kim Hasenkrug · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI

Abnormalities in gene expression in therapy-related MDS

$563,931
Ravi Bhatia · Beckman Research Institute/City Of Hope · R01 · FY2007 · HL

Pre-clinical Studies of Therapy for Myelodysplastic Syndrome

$563,844
Peter Aplan · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Gene expression in mature neutrophils

$563,701
Univ Of Massachusetts Med Sch Worcester · R01 · FY2005 · DK

CHANGING PARENTAL BELIEFS IN PEDIATRICS ONCOLOGY

$563,563
Childrens Hospital Of Philadelphia · R01 · FY2004 · CA

Understanding and targeting bone marrow microenvironment in myelofibrosis

$563,550
Lei Ding · Columbia University Health Sciences · R01 · FY2024 · HL

A Drug Delivery Strategy for Targeted Therapy of Chronic Lymphocytic Leukemia

$563,511
Ben Shen · University Of Florida · R01 · FY2022 · CA

Cancer Genomics

$563,379
Thomas Ried · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA

Project 2: Defining the role of megakaryocyte abnormalities in the progression of primary myelofibrosis

$563,362
Anna R Migliaccio · Icahn School Of Medicine At Mount Sinai · P01 · FY2018 · CA

Flow Cytometry

$563,202
Michael W Andreeff · University Of Tx Md Anderson Can Ctr · P30 · FY2010 · CA